Malignant News and Research

RSS

Ludwig-developed antibody drug for deadly brain cancer may have broader applications

A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor, a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme.

10 Jul 2018

Researchers reveal more accurate, faster robot for breast biopsy

Last year, the University of Twente revealed the world's most accurate 3D-printed biopsy robot. This time, during the Surgical Robot Challenge at the international Hamlyn Symposium in London, the researchers revealed the latest version.

4 Jul 2018

Specific type of satellite RNA induces breast cancer, shows study

Only some of us have satellite TV in our homes, but all of us have satellite DNA in cells in our bodies. Working copies of satellite DNA are high in certain types of cancer, such as breast and ovarian.

4 Jul 2018

Viral immunotherapy shows promise to treat pediatric brain tumors

A viral immunotherapy using a herpes virus to treat brain tumors has been shown to be safe and well-tolerated in a pediatric study from the University of Alabama at Birmingham and Children's of Alabama.

4 Jul 2018

Northwestern Memorial Hospital completes its first robotic-assisted minimally invasive tracheoplasty

A well-known thoracic surgeon successfully completed Northwestern Memorial Hospital's first robotic-assisted minimally invasive tracheoplasty using the da Vinci Xi Surgical System to help repair the collapse of the central airway including the trachea and bronchi.

3 Jul 2018

Rabin Medical Center in Israel selects RayStation for radiation therapy treatment planning

Rabin Medical Center has selected RayStation for radiation therapy treatment planning at its Davidoff Cancer Center, located in Petah Tikva, Israel. This is the first order from a clinic in Israel, and the installation will include licenses for 3DCRT, IMRT, VMAT and adaptive therapy.

From RaySearch Laboratories AB 3 Jul 2018

Unique virus appears to enhance our immune system rather than weakening it

Our immune system is at its peak when we're young, but after a certain age, it declines and it becomes more difficult for our bodies to fight off new infections.

3 Jul 2018

Cilia appears to play key role in formation of melanoma

Most cells in the human body have a cilium, a slender cell protuberance that picks up signals from the cell's external environment.

2 Jul 2018

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.

30 Jun 2018

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.

30 Jun 2018

Study finds sex-based differences in genetic risk factors for developing gliomas

Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults.

29 Jun 2018

Genetic biomarker can help predict survival outcomes in patients with certain gliomas

A DNA-level biomarker (MGMT promoter methylation) can be used to help predict survival outcomes in patients with high-risk, low-grade gliomas, according to a new study conducted through the NRG Oncology/RTOG collaborative clinical trials group and led by scientists at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

28 Jun 2018

DNA methylation predicts survival outcome in patients with glioma

A new study has shown that survival rates among patients with glioma double if the tumor carries a methylated MGMT gene.

28 Jun 2018

MDxHealth releases positive data demonstrating value of SelectMDx test for prostate cancer patients

MDxHealth SA, today announced the publication of positive data demonstrating the value of the SelectMDx liquid biopsy test for Prostate Cancer in guiding patient management for men being considered for multiparametric MRI and the clinical utility in guiding biopsy decisions in real-world clinical practice.

From MDxHealth 28 Jun 2018

Unbiased approach reveals how to restore breast cancer drugs’ tumor-killing potential

More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells-- known as the PI3 kinase (PI3K) pathway--but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.

26 Jun 2018

Malignant News and Research

Ludwig-developed antibody drug for deadly brain cancer may have broader applications

Researchers reveal more accurate, faster robot for breast biopsy

Specific type of satellite RNA induces breast cancer, shows study

Viral immunotherapy shows promise to treat pediatric brain tumors

Northwestern Memorial Hospital completes its first robotic-assisted minimally invasive tracheoplasty

Rabin Medical Center in Israel selects RayStation for radiation therapy treatment planning

Unique virus appears to enhance our immune system rather than weakening it

Cilia appears to play key role in formation of melanoma

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

Study finds sex-based differences in genetic risk factors for developing gliomas

Genetic biomarker can help predict survival outcomes in patients with certain gliomas

DNA methylation predicts survival outcome in patients with glioma

MDxHealth releases positive data demonstrating value of SelectMDx test for prostate cancer patients

Unbiased approach reveals how to restore breast cancer drugs’ tumor-killing potential

Novel smart probe may improve post-surgical outcomes for cancer patients

Risk of heart attacks, strokes and vascular occlusions found to be higher in cancer patients

Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma

Targeting cells involved in blood vessel formation could hinder brain tumor growth

Scientists discover genetic causes underlying group of related infant cancers

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News